Carregant...
Recent Advances in the Development of Immunotherapies for Tauopathies
The use of immunotherapy for Alzheimer’s Disease (AD) has traditionally focused on the amyloid-β (Aβ) peptide and has shown great potential in both animal and human studies. However an emerging body of work has begun to concentrate on tau and to develop immunization protocols designed to decrease ta...
Guardat en:
| Autors principals: | , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
2010
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3125641/ https://ncbi.nlm.nih.gov/pubmed/20970422 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.expneurol.2010.10.007 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|